These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 25022573

  • 1. MDM2 molecular imaging for the prediction of chemotherapeutic sensitivity in human breast cancer xenograft.
    Fu P, Sun L, Cao X, Li L, Zhao C.
    Mol Imaging; 2014; 13():. PubMed ID: 25022573
    [Abstract] [Full Text] [Related]

  • 2. Molecular imaging of MDM2 messenger RNA with 99mTc-labeled antisense oligonucleotides in experimental human breast cancer xenografts.
    Fu P, Shen B, Zhao C, Tian G.
    J Nucl Med; 2010 Nov; 51(11):1805-12. PubMed ID: 20956468
    [Abstract] [Full Text] [Related]

  • 3. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
    Xiong J, Yang Q, Li J, Zhou S.
    Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
    [Abstract] [Full Text] [Related]

  • 4. Experimental therapy of human prostate cancer by inhibiting MDM2 expression with novel mixed-backbone antisense oligonucleotides: in vitro and in vivo activities and mechanisms.
    Wang H, Yu D, Agrawal S, Zhang R.
    Prostate; 2003 Feb 15; 54(3):194-205. PubMed ID: 12518324
    [Abstract] [Full Text] [Related]

  • 5. Antisense anti-MDM2 oligonucleotides as a novel therapeutic approach to human breast cancer: in vitro and in vivo activities and mechanisms.
    Wang H, Nan L, Yu D, Agrawal S, Zhang R.
    Clin Cancer Res; 2001 Nov 15; 7(11):3613-24. PubMed ID: 11705884
    [Abstract] [Full Text] [Related]

  • 6. ShRNA targeting Notch1 sensitizes breast cancer stem cell to paclitaxel.
    Mao J, Song B, Shi Y, Wang B, Fan S, Yu X, Tang J, Li L.
    Int J Biochem Cell Biol; 2013 Jun 15; 45(6):1064-73. PubMed ID: 23500524
    [Abstract] [Full Text] [Related]

  • 7. Time course of Paclitaxel-induced apoptosis in an experimental model of virus-induced breast cancer.
    Erba PA, Manfredi C, Lazzeri E, Minichilli F, Pauwels EK, Sbrana A, Strauss HW, Mariani G.
    J Nucl Med; 2010 May 15; 51(5):775-81. PubMed ID: 20395330
    [Abstract] [Full Text] [Related]

  • 8. Antisense anti-MDM2 mixed-backbone oligonucleotides enhance therapeutic efficacy of topoisomerase I inhibitor irinotecan in nude mice bearing human cancer xenografts: In vivo activity and mechanisms.
    Wang H, Wang S, Nan L, Yu D, Agrawal S, Zhang R.
    Int J Oncol; 2002 Apr 15; 20(4):745-52. PubMed ID: 11894120
    [Abstract] [Full Text] [Related]

  • 9. The effect of Tc-99m-labeled MDM2 antisense oligonucleotide on gene expression in human breast cancer MCF-7 cells.
    Zhao C, Fu P, Sheng Y, Li Z.
    J Exp Ther Oncol; 2007 Apr 15; 6(4):297-303. PubMed ID: 18038763
    [Abstract] [Full Text] [Related]

  • 10. Gossypol has anti-cancer effects by dual-targeting MDM2 and VEGF in human breast cancer.
    Xiong J, Li J, Yang Q, Wang J, Su T, Zhou S.
    Breast Cancer Res; 2017 Mar 09; 19(1):27. PubMed ID: 28274247
    [Abstract] [Full Text] [Related]

  • 11. Estrogen receptor α attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors.
    Chang J, Sui M, Fan W.
    Breast Cancer Res Treat; 2012 Aug 09; 134(3):969-80. PubMed ID: 22374518
    [Abstract] [Full Text] [Related]

  • 12. S100A6 inhibits MDM2 to suppress breast cancer growth and enhance sensitivity to chemotherapy.
    Qi M, Yi X, Yue B, Huang M, Zhou S, Xiong J.
    Breast Cancer Res; 2023 May 22; 25(1):55. PubMed ID: 37217945
    [Abstract] [Full Text] [Related]

  • 13. Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models.
    Miyake H, Nelson C, Rennie PS, Gleave ME.
    Cancer Res; 2000 May 01; 60(9):2547-54. PubMed ID: 10811138
    [Abstract] [Full Text] [Related]

  • 14. The effect of seal oil on paclitaxel induced cytotoxicity and apoptosis in breast carcinoma MCF-7 and MDA-MB-231 cell lines.
    Wang Z, Butt K, Wang L, Liu H.
    Nutr Cancer; 2007 May 01; 58(2):230-8. PubMed ID: 17640170
    [Abstract] [Full Text] [Related]

  • 15. Antisense anti-MDM2 oligonucleotides as a novel approach to the treatment of glioblastoma multiforme.
    Prasad G, Wang H, Agrawal S, Zhang R.
    Anticancer Res; 2002 May 01; 22(1A):107-16. PubMed ID: 12017271
    [Abstract] [Full Text] [Related]

  • 16. [Screening and their anti-tumor activity of antisense oligodeoxynucleotides targeting KDR mRNA in breast cancer MCF-7 cells].
    Zheng SJ, Lin RX, Xia Y, Bo XC, Ren H, Zhong S, Wang SQ.
    Zhonghua Zhong Liu Za Zhi; 2006 Apr 01; 28(4):248-52. PubMed ID: 16875620
    [Abstract] [Full Text] [Related]

  • 17. Combined targeting of epidermal growth factor receptor and MDM2 by gefitinib and antisense MDM2 cooperatively inhibit hormone-independent prostate cancer.
    Bianco R, Caputo R, Caputo R, Damiano V, De Placido S, Ficorella C, Agrawal S, Bianco AR, Ciardiello F, Tortora G.
    Clin Cancer Res; 2004 Jul 15; 10(14):4858-64. PubMed ID: 15269162
    [Abstract] [Full Text] [Related]

  • 18. Antitumor activity of paclitaxel against human breast carcinoma xenografts serially transplanted into nude mice.
    Kubota T, Matsuzaki SW, Hoshiya Y, Watanabe M, Kitajima M, Asanuma F, Yamada Y, Koh JI.
    J Surg Oncol; 1997 Feb 15; 64(2):115-21. PubMed ID: 9047247
    [Abstract] [Full Text] [Related]

  • 19. [Technetium-99m labeled synaptotagmin I C2A detection of paclitaxel-induced apoptosis in non-small cell lung cancer].
    Wang F, Fang W, Ji SD, Meng QL, Li Y, Fan KW, Wang ZZ.
    Zhonghua Zhong Liu Za Zhi; 2007 May 15; 29(5):351-4. PubMed ID: 17892130
    [Abstract] [Full Text] [Related]

  • 20. A preliminary study of imaging paclitaxel-induced tumor apoptosis with (99)Tc(m)-His10-Annexin V.
    Zheng YM, Wang F, Fang W, Hua ZC, Wang ZZ, Meng QL, Yan J.
    Chin Med J (Engl); 2013 May 15; 126(15):2928-33. PubMed ID: 23924470
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.